论文部分内容阅读
目的:研究分析降纤酶治疗脑血栓形成急性期的应用价值。方法:选取本院2015年3月~2016年3月期间诊治的脑血栓形成急性期患者79例,采取前瞻性分组研究进行分析,先行随机将患者分为2组,观察组40例,采用降纤酶治疗,对照组39例,行常规纤溶酶治疗,对比两组患者临床疗效。结果:观察组患者治疗后显效22例,有效16例,无效2例,治疗总有效率高达95.00%(38/40),对照组患者治疗后显效18例,有效14例,无效7例,治疗总有效率为82.05%(32/39),两组对比观察组显疗效著高于对照组,(P<0.05)差异有统计学意义。结论:在脑血栓成形急性期应用降纤酶进行治疗,可迅速溶解血栓,改善机体症状,安全性较高,值得推广应用。
Objective: To study the clinical value of defibrase in the treatment of acute cerebral thrombosis. Methods: A total of 79 patients with acute cerebral thrombosis diagnosed and treated during our hospital from March 2015 to March 2016 were selected and prospectively divided into two groups randomly: observation group (40 cases) In the control group, 39 cases were treated with fibrinolytic enzyme, and routine plasmin was used to compare the clinical curative effect of the two groups. Results: In the observation group, 22 cases were markedly effective after treatment, 16 cases were effective and 2 cases were ineffective. The total effective rate was as high as 95.00% (38/40). In the control group, 18 cases were markedly effective after treatment, 14 cases were effective, 7 cases were ineffective, The total effective rate was 82.05% (32/39). The curative effect of the two groups was significantly higher than that of the control group (P <0.05), the difference was statistically significant. Conclusion: The treatment of defibrase during the acute phase of cerebral thrombosis can rapidly dissolve thrombus, improve the symptoms of the body and have higher safety. It is worth popularizing and applying.